Through LRP1-mediated activation of the AKT/ERK1/2 pathway, PAI-1 promotes the migration and invasion of both cancer cells and macrophages, correlating with poor prognosis and identifying the PAI-1/LRP1 axis as a promising therapeutic target (36). The gene discussed is AKT1; the disease is cancer.